Marmol v. St. Jude Medical Center
132 F. Supp. 3d 1359
M.D. Fla.2015Background
- Plaintiff implanted a Class III St. Jude Riata model 1582 ICD lead (PMA-approved) and later experienced device shocks and lead malfunction; removal surgery failed to extract the lead.
- Plaintiff alleges manufacturing defects (conductor extrusion, compromised insulation, uneven diameters, improper curing/sterilization/processing/crimping) and inadequate warnings/post-market reporting, tied to violations of PMA specifications and FDA regulations (CGMP/QSR/MDRs).
- Plaintiff filed state-law claims: strict liability (manufacturing defect), negligent manufacturing defect, and failure to warn; defendants moved to dismiss under Rule 12(b)(6), invoking MDA preemption and pleading deficiencies.
- Court accepted factual allegations as adequately pled for Rule 8 purposes but examined preemption and state-law availability as dispositive legal issues.
- Court concluded Florida law does not recognize private causes of action to enforce FDA requirements and the MDA/FDCA preclude a private federal remedy; claims dismissed without prejudice with leave to amend.
Issues
| Issue | Plaintiff's Argument | Defendant's Argument | Held |
|---|---|---|---|
| Whether manufacturing-defect claims are adequately pled | Allegations link specific manufacturing failures to PMA/regulatory violations and plaintiff's injuries | Claims are conclusory and insufficient under Rule 8 | Pled sufficiently at motion-to-dismiss stage (claims plausible) |
| Whether manufacturing-defect claims are expressly preempted under MDA §360k(a) | Claims parallel federal requirements (PMA or other FDA regs like CGMP/QSR), not additional | PMA approval establishes federal requirements and state claims differing from PMA are preempted; some specs cited may not be in PMA | Court needn't resolve express-preemption fully because claims fail under Florida law; judicial notice of PMA contents denied at this stage |
| Whether Florida law permits private enforcement of FDA/MDA requirements | State-law duties can ‘‘parallel’’ federal requirements and be enforced | Florida does not recognize private causes of action to enforce FDA requirements | Florida law bars private actions to enforce FDA/MDA requirements; manufacturing claims dismissed on that basis |
| Whether failure-to-warn (post‑market reporting) claim is viable | Duty to report to FDA affects physician warnings and thus patient safety; claim limited to FDA reporting requirements | Failure-to-report claims are actually FDCA claims; no private right to enforce MDRs; preempted/impliedly preempted | Failure-to-warn claim premised on FDA reporting is impliedly preempted and not recognized under Florida law; dismissed |
Key Cases Cited
- Riegel v. Medtronic, Inc., 552 U.S. 312 (2008) (PMA approval triggers federal requirements and §360k express preemption analysis)
- Buckman Co. v. Plaintiffs’ Legal Comm., 531 U.S. 341 (2001) (no private right of action to enforce FDCA; such claims are impliedly preempted)
- Wolicki-Gables v. Arrow Int’l, Inc., 634 F.3d 1296 (11th Cir. 2011) (parallel‑claims standard: state requirement must be genuinely equivalent and plaintiffs must identify particular PMA specifications violated)
- In re Medtronic, Inc., Sprint Fidelis Leads Prods. Liab. Litig., 623 F.3d 1200 (8th Cir. 2010) (discussing narrow gap between express and implied preemption for PMA devices)